Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T19:18:12.677Z.
Calculation as of: 2026-10-06T19:18:12.677Z.
Quote observation: 2026-10-06T19:15:21.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 80dc1f4e8b31b1f0ec5b4a1e5c631a71efe14c3ee5142d993ef0c896d26e8132
PE RATIO
N/A
Market Cap
$127.72M
PE Ratio
N/A
TTM Avg
1239.77
3Y Avg
1350.84
5Y Avg
1350.84
Market Cap
$125.21M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$132.27M
PE Ratio
N/A
TTM Avg
194.70
3Y Avg
73.96
5Y Avg
73.96
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pyxis Oncology, Inc. (PYXS) | $128.34M | N/A | N/A | N/A | N/A |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $127.72M | N/A | 1239.77 | 1350.84 | 1350.84 |
| Entera Bio Ltd. (ENTX)vs › | $126.18M | N/A | 2.13 | 2.46 | 2.46 |
| TuHURA Biosciences, Inc. (HURA)vs › | $125.45M | N/A | N/A | N/A | N/A |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $125.21M | N/A | N/A | N/A | N/A |
| Health Catalyst, Inc. (HCAT)vs › | $131.90M | N/A | N/A | N/A | N/A |
| Freenome, Inc. (FRNM)vs › | $132.47M | N/A | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $132.27M | N/A | 194.70 | 73.96 | 73.96 |
| LifeMD, Inc. (LFMD)vs › | $132.96M | N/A | 18.93 | 18.93 | 18.93 |
| Cibus, Inc. (CBUS)vs › | $120.99M | N/A | N/A | N/A | N/A |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$2.03
Forward EPS (Est.)
$-1.22
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
